Annual report pursuant to Section 13 and 15(d)

Schedule of Changes in Fair Value of Level 3 Valued Instruments (Details)

v3.23.1
Schedule of Changes in Fair Value of Level 3 Valued Instruments (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]    
Additions $ (250)
2020 Convertible Note [Member]    
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]    
Beginning Balance
Additions   3,746
Measurement adjustments   4
Settlement   (3,750)
Ending Balance  
Warrants [Member]    
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]    
Beginning Balance
Additions   635
Measurement adjustments   (214)
Settlement   (421)
Ending Balance  
Embedded Derivative [Member]    
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]    
Beginning Balance 1,690
Additions   325
Measurement adjustments   250
Settlement   (2,265)
Ending Balance  
Vivo Pharm Pty Ltd [Member]    
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]    
Beginning Balance 11,000
Additions 11,000
Measurement adjustments (5,528)
Settlement (5,472)
Ending Balance $ 11,000